Collegium Pharmaceutical (COLL) Treasury Shares (2014 - 2026)

Collegium Pharmaceutical's Treasury Shares history runs 9 years deep, the most recent figure standing at $222.5 million for Q1 2026.

• On a quarterly basis, Treasury Shares rose 12.66% year-over-year to $222.5 million in Q1 2026; TTM through Mar 2026 was $222.5 million, a 12.66% increase from a year earlier, with the FY2025 full-year figure at $222.5 million, up 12.66% from the prior year.
• Treasury Shares steadied at $222.5 million in Q1 2026 per COLL's latest filing, from $222.5 million in the prior quarter.
• Across five years, Treasury Shares topped out at $9.0 million in Q3 2025 and bottomed at $2.5 million in Q1 2022.
• The 5-year median for Treasury Shares is $6.3 million (2023), against an average of $6.0 million.
• Across the five-year window, Treasury Shares surged 1138.48% in 2023 and increased 12.66% in 2025, its largest moves.
• Year by year, Treasury Shares stood at $61.9 million in 2022, then soared by 121.85% to $137.4 million in 2023, then surged by 43.76% to $197.5 million in 2024, then rose by 12.66% to $222.5 million in 2025, then changed by 0.0% to $222.5 million in 2026.
• Per Business Quant, the three latest COLL Treasury Shares figures stand at $222.5 million (Q1 2026), $222.5 million (Q4 2025), and $222.5 million (Q3 2025).